This development of MRI-visual order-disorder structures for cancer nanomedicine explores pH-trigger mechanism for theragnosis of tumour hallmark functions. Superparamagnetic iron oxide nanoparticles (SPIONs) stabilised with amphiphilic poly(styrene)-b-poly(acrylic acid)-doxorubicin with folic acid (FA) surfacing is employed as a multi-functional approach to specifically target, diagnose and deliver drugs via a single nanoscopic platform for cancer therapy. The functional aspects of the micellar nanocomposite is investigated in vitro using human breast SkBr3 and colon cancer HCT116 cell lines for the delivery, release, localisation and anticancer activity of the drug. Our work shows, for the first time, concentration dependent T 2 -weighted MRI contrast for a monolayer of clustered cancer cells. The pH tunable order-disorder transition of the core-shell structure induces the relative changes in MRI contrast. The outcomes elucidate the potential of this material for smart cancer theranostics by delivering non-invasive real-time diagnosis, targeted therapy and monitoring the course and response of the action before, during and after the treatment regimen.
Introduction
Considerable progress has already been made in the development of nanomaterials for drug delivery as well as disease diagnostics. One recent trend is the exploration of nanotheranostics, combining both diagnostic and therapeutic elements at the nano scale. [1, 2] Systems merging therapeutic agents, molecular targeting and diagnostic imaging capabilities are emerging as the next generation of multifunctional remedies. [3] Drug targeting and delivery including the use of liposomes, micelles, dendrimers, nanotubes, and nanoparticles have been widely reported. [4] [5] However, research enabling real time tracking of such systems is in its infancy. [6] The appropriate delivery of the drug to its target through site-specific stimuli such as inflammation, pH and ionic strength can further facilitate drug delivery from the carrier in a well-controlled manner. In addition, heterogeneous and adaptive diseases like cancer require fresh therapeutic protocols which are custom-fitted to the cancer type and individual patient. [7] Current problems associated with conventional cancer chemotherapies include insolubility of drugs in aqueous medium, delivery of sub-therapeutic doses to target cells, lack of bioavailability and most importantly, non-specific toxicity to normal tissues. The recent contributions of nanotechnology address possible solutions to these conundrums. [8] Likewise, challenges remain with respect to delivery to specific sites, real time tracking of the system and control over the release system after the drug has been transported to the target site. [9] In the present contribution, we formulated a module using super paramagnetic iron oxide nanoparticles (SPION) as the core, stabilised with stimuli-responsive hydrazide-terminated poly(styrene)-b-poly(acrylic acid) block copolymer (PS-b-PAA) as the shell, which was loaded with the anticancer drug, doxorubicin (DOx) and with peripheral surfacing by folic acid. The covalent linkage of folate served to recognise the cancer site and the pH-sensitive DOx bonds delivered effective release of the drug at the tumour site. [10] The SPION core of the module was chosen for its super paramagnetic properties, [11] which facilitates non-invasive visualisation via magnetic resonance imaging. Flexible surface properties further enrich the current state of the art by core-shell nanoassembly. [12] From a pharmacological perspective, we sought to endow the core with a reasonable circulation time, good lesion accumulation rate and high extravasation rate. [13] The use of SPION as a core provides the potential for it to be guided to target sites by means of an external magnetic field and it can also be heated to provide local hyperthermia for cancer therapy. [14] Moreover, the stimuli responsive order-disorder transition-enabled block copolymer, PS-b-PAA, had dual advantages from both the synthetic and application aspects. [15] The stimuli-responsive order-disorder core-shell nanoassembly was used to solubilise the DOx in the hydrophobic core of the styrene and hence, reduce the possibility of unintended exposure and the consequent cytotoxicity for normal cells.
Moreover, the fate of tumour progression and metastasis is heavily dependent on the associated microenvironment. [16] The intrinsic acidic nature of the intratumour microenvironment is mainly guided by anaerobic and aerobic glycolysis followed by accumulation of lactic acid produced by the cancer cells. The pH dependent T 2 -weighted contrast properties of the synthesised SPION@PS-b-PAA-DOx/FA, in turn will sense the differential pH dependent cancer microenvironment and help in defining the case-by-case therapeutic protocol for personalised nanomedicine. [17] In summary, we developed a pH-triggered smart theranostic nanostructure for cancers which could be triggered by differential ionic properties of the tumour microenvironment. The methodology could greatly benefit the current investigation of new medications and diagnostics procedures for integrated cancer care. Furthermore, this methodology will help to improve the efficacy of the treatment by the early stage management of disease. This is very important in terms of point-of-care diagnosis, life-saving, timely treatment and cost cutting.
Results and discussion

Synthesis and Characterisation of SPION@PS-b-PAA-DOx/FA
The SPION@PS-b-PAA-DOx/FA was synthesised using a three-step procedure as shown in Scheme 1. In the first step, the hydrazide terminated PS-b-PAA was self-assembled around the SPION. The SPION contained <1.0% short chains of PEG as stabilising/chelating agent, which in turn helped to form the core-shell assembly of SPION@PS-b-PAA. Further, in the second step, the DOx was conjugated with nanomicelles through the hydrazone linkage via the hydrazide moiety. The hydrazone linkage was formed by the carbonyl group (>C=O) of the DOx and the hydrazide ( Earlier attempts to conjugate the DOx to a nanocarrier were successful in terms of chemistry, yet questionable with respect to the level of toxicity of the molecules used in the conjugation process. The folic acid functionalised nanomicelles were prepared using poly(benzyl L-aspartate)-b-poly(ethylene glycol) block copolymer and thereafter DOx was attached at the end for the tumour-targeted drug delivery. [18, 19] The attachment of terminal moieties, i.e., DOx and folic acid, was achieved by an extensive multi-step chemical procedure. Furthermore, hydrazone linkage with DOx was formed with anhydrous hydrazine, which is a highly toxic substance. [20] In the current study, the design and synthesis are unique and novel because of the availability of terminal responsive functional groups on the amphiphilic SPION@PS-b-PAA core-shell composite for the attachment of DOx and vitamin B9. Folic acid is an essential water soluble vitamin (i.e., vitamin B9) mandatory for cell proliferation; however folate receptors are overexpressed on cancer cells. Due to the high binding capability of such vitamin, it provided a useful recognition molecule for tumour-targeted drug delivery. [21] The folic acid binds to the folate receptors on the tumour cells by active targeting, which leads to receptor-mediated endocytosis and controlled release of drug delivered to the cancer cells. [22] The hydrazone linkage is sensitive to low pH and hence the attached DOx in the nanocarrier is cleaved easily by the highly acidic environment in the tumour cells resulting in controlled release. Moreover, the inner hydrophobic shell of SPION@PS-b-PAA retains DOx without leakage during transportation. This mechanism helps to reduce the side effects of toxicity, for example, killing of normal cells and non-specific drug release.
Properties of SPION@PS-b-PAA-DOx/FA Nanomicelles
The SPION@PS-b-PAA-DOx/FA composite formed core-shell micelles in aqueous solutions, balancing hydrophilic-to-hydrophobic functions. The hydrophobic property derived from the tendency of the polystyrene block of the copolymer to aggregate away from the aqueous phase to build the inner shell upon the SPION cores, whereas the hydrophilic part came from the water soluble blocks of PEG ligands and poly(acrylic acid)
immersed in the water to formulate the outer shell of composite core-shell micelles. [18] The that styrene is selectively attached with the hydrophobic segments of the core-shell micelles structure in aqueous medium. [19, 23] Figure 2 shows the relation between intensity I 330 and I 334 ratio of the pyrene excitation spectra vs. SPION@PS-b-PAA-DOx/FA nanomicelle size within such a range can also avoid renal clearance. [24] The size of nanomicelle within this range could be promising for injectable anti-cancer drug delivery to the target moieties by extravasation, superior permeation and receptor-mediated endocytosis.
Drug Release
The DOx content entrapped into the SPION@PS-b-PAA-DOx/FA micelles was found to be 19 wt%. Figure 3a shows [25]
The pH dependent magnetisation of SPION@PS-b-PAA-DOx/FA micelles was recorded at pH 5.3, 6.2 and 7.4. The variation in M-H curves with respect to pH is shown in Figure 3b . It was observed that magnetisation of micelles at each pH point as chosen for the drug delivery study was virtually saturated at high Submitted to 8 magnetic field similar to crystallised SPIONs. [26] At physiological temperatures, a weak magnetic hysteresis was observed at pH 7.4, whereas, hysteresis loops are symmetric around the origin at both malignancy pH points.
The effect of pH on the magnetisation is clearly perceptible in the evolution of the hysteresis loops, indicating that the SPION core in the SPION@PS-b-PAA-DOx/FA micelle introduced a superparamagnetic contribution by influencing the hydrodynamic volume of the pH-responsive poly(acrylic acid) blocks. From the statistical mechanics, the magnetic particles in the liquid follow the relation-
Here,
where n is particles per cm 3 , C is a constant, p is the magnetic moment per particle, H is the magnetic field, k is Boltzman constant, T is absolute temperature, D is diameter of particle and M d is magnetisation. From Equation (2), it is clear that superpramagnetic SPION@PS-b-PAA-DOx/FA micelles at pH 5.3, 6.2 and 7.4 are dependent on the size and density of the core-shell structure. This may be attributed to factors including variation of the oxygen stoichiometry of Fe-O-Fe from core to shell, variation in micellar size and changes in the magnetic moment. [27] [28] [29] Thus, modules are released the DOx by three principal mechanisms, i.e., erosion, swelling and diffusion controlled by order-disorder core-shell structure. [30, 31] The SPION@PS-b-PAA-DOx/FA nanomicelle showed an initial burst release followed by a controlled drug delivery that obeys a diffusion-controlled mechanism; however, the diffusion rates at each stage of the DOx release varied greatly, suggesting two different processes may be taking place. Initially, drug release occurred relatively fast, up to 8h. It is evident that the drug present on the surface of inner shell or at the interface between the core and shell of micelle may be exposed to the release medium thus enabling order-disorder SPION@PS-b-PAA-DOx/FA transition using the pH-responsive hydrodynamic rate of poly(acrylic acid) blocks in the coreshell assembly (Figure 3c) . This hypothesis was supported by the results from the bloodstream mimic pH at 7.4.
In this case, diffusion of DOx was dramatically slower than pH points of metastatic spread and direct metastatic stages.
Cell Viability Assay
The phasecontrast microscopy showed significant variation in the cell morphology for SPION@PS This increased potency and efficacy of the SPION@PS-b-PAA-DOx/FA might be due to the greater uptake and retention of the drug inside the intracellular environment. The MTT results were again in agreement with the cellular morphology changes through phase-contrast microscopy.
Drug Uptake and Localisation
The uptake and delivery of the drug by SPION@PS-b-PAA-DOx/FA was confirmed by confocal microscopy.
One of the major challenges to select anti-cancer drugs is specifying the target molecule and the target site.
There are two layers of selection, firstly, the drug should be specified to cell types or tissue types. [33] In the second layer the drug should find the specific target including DNA, protein, RNA, biomolecule etc. within the intracellular environment. For example, we have used DOx as anti-cancer model drug for a SPION@PS-b-PAADOx/FA theranostic module. This has been used since 1960 for a wide spectrum of cancers such as rhabdomyosarcoma, breast cancer, adult acute leukemia, endometrial cancer, stomach cancer, cervical cancer and non-Hodgkin's lymphoma, to name a few. [34] DOx is a DNA targeting intercalating agent that should be dimensionally fitted during the interaction. [35] In order to investigate the criteria to serve as an effective theranostic SPION@PS-b-PAA-DOx/FA module, we have visualised the intracellular localisation of the drug ( Figure 5 ).
The co-localisation study shows that the released DOx from nanocarrier was functionally effective to bind with the nuclear matter, i.e., DNA (Figure 5 ) in the SKBR3 and HCT116. The release of the drug from the carrier was necessary for the present system as otherwise it will be sterically forbidden for uptake through the nuclear membrane as well as intercalation within the DNA strands. The propensity for drug inclusion within the nucleus was illustrated by the overlap coefficient for the nucleus image versus the drug image of 0.75 and 0.89 for SKBR3 and HCT116, respectively.
In vitro Magnetic Resonance Imaging (MRI)
The T Tromodrof [37] . 
Conclusions
SPION@PS
4.3.
Synthesis of SPION@PS-b-PAA-DOx
The pH-responsive bonding of DOx on SPION@PS-b-PAA was done using a hydrazone coupling reaction between the hydrazide terminus of SPION@PS-b-PAA and amine group of Dox. [34] In a typical experiment, 50 mg of SPION@PS-b-PAA was reacted with DOx (75 µL, 10 mg/mL) in aqueous medium. The reaction was carried out at 25 o C for 48h. The resulting SPION@PS-b-PAA-DOx was dialysed with a molecular weight cutoff 10 kDa against phosphate buffer solution (PBS, pH 8.5). The drug loading was determined using UV-vis spectrophotometer at a wave length of 480 nm.
Preparation of SPION@PS-b-PAA-DOx/FA Nanomicelles
The cancer cell-selective surface of SPION@PS-b-PAA-DOx was produced with vitamin B 9 via coupling chemistry. [19] Briefly, the acid group of SPION@PS-b-PAA was activated using EDC (0.38 mM) and NHS 
4.6.
Drug Release Study
The drug release studies were performed in PBS at pH 5. The cells were then washed with PBS and fixed with 4% paraformaldehyde. The nuclei were stained using 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI). The propensity of the drug inclusion within the nucleus was calculated by measuring the overlap co-efficient using Zen 2009, the image acquisition and analysis software.
In vitro Magnetic Resonance Imaging (MRI)
The in vitro MRI experiments were performed using a 1.5 Tesla Philips Achieva imaging system. The magnetic microscopic transverse relaxation time (T 2 ) weighted images were measured for various concentrations (10, 25, 50, 100, 250, and 250 g/ml). A pH dependent study has been done using 250 g/ml of SPION@PS-b-PAADox/FA at pH 7.2, 6.2 and 5.3. All the samples were run under Turbo Gradient Spin Echo (GRASE) sequences at room temperature. The T 2 weighted intensities were measured in the region of interest. The T 2 weighted images were acquired using standard methods [38] with small modifications. In brief, the parameters are as with references from the earlier reports. In brief, each image-stack collected within one acquisition by reading a series of echoes is considered for comparing the intensities. We have computed the relative difference between voxels (3d pixels) in each sample by extracting the pixel index. The detailed script that has been used for the evaluation of the mean, median and standard deviations of the pixel intensities has been given in the supplementary section (S1). 
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